Arbutus Biopharma (ABUS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Arbutus Biopharma (ABUS) Company Statistics | The Fly

Arbutus Biopharma

· ABUS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

916.834 M

-3.18%

General

Market Cap: $946.95M
Enterprise Value: $862.51M
Shares Outstanding: 197,540,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 99.98%
Operating Margin: 81.01%
Net Profit Margin: 84.23%
FCF Margin: -13.55%
ROA: 55.85%
ROE: 90.98%
ROIC: 54.29%
Current Ratio: 81.42
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: 5.73
PEG: —
P/S: 4.83
P/FCF: —
P/B: 3.39
EV/EBITDA: 5.63

Growth

Rev 1Y: 128.21%
Rev 1Y Fwd Est: 1193.76%
Rev 3Y (CAGR): -28.80%
Rev 5Y (CAGR): 15.29%

Income Statement (TTM)

Revenue: $181.72M
Gross Margin: 99.98%
Operating Expenses: $34.47M
Operating Income: $147.22M
Net Profit: $153.05M

Balance Sheet

Rev 10Y (CAGR)

-5.53%

EPS 1Y

—

EPS 1Y Fwd Est

—

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $19.17M
Working Capital: $270.52M
Total Assets: $274.03M
Net Debt: -$15.55M
Total Liabilities: $15.29M
Total Equity: $258.73M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$24.63M
Cash Flow from Investing: -$10.84M
Cash Flow from Financing: $17.25M
Free Cash Flow: -$24.63M
Capital Expenditures: $0